Viewing Study NCT04829604


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-25 @ 5:32 PM
Study NCT ID: NCT04829604
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2021-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Sponsor: Ambrx, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module